 | • レポートコード：QYR9ST08783 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、皮膚肥満細胞症の治療の世界市場について調査・分析し、皮膚肥満細胞症の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗ヒスタミン剤、コルチコステロイド、肥満細胞安定剤、交感神経刺激薬（エフィネフリン）、光線化学療法）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の皮膚肥満細胞症の治療市場動向 ・主要企業別マーケットシェア ・皮膚肥満細胞症の治療の種類別市場規模2014-2019 （抗ヒスタミン剤、コルチコステロイド、肥満細胞安定剤、交感神経刺激薬（エフィネフリン）、光線化学療法） ・皮膚肥満細胞症の治療の用途別市場規模2014-2019 （病院、診療所、その他） ・皮膚肥満細胞症の治療の北米市場：主要企業・種類別/用途別市場規模 ・皮膚肥満細胞症の治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・皮膚肥満細胞症の治療の中国市場：主要企業・種類別/用途別市場規模 ・皮膚肥満細胞症の治療の日本国内市場：主要企業・種類別/用途別市場規模 ・皮膚肥満細胞症の治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・皮膚肥満細胞症の治療のインド市場：主要企業・種類別/用途別市場規模 ・皮膚肥満細胞症の治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Novartis AG、Mylan NV、Teva Pharmaceutical Industries Ltd.、Bausch Health Companies Inc.、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.、Sanofi S.A.、Johnson & Johnson、Bayer AG、Mallinckrodt Pharmaceuticals） ・皮膚肥満細胞症の治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Cutaneous mastocytosis is a form of mastocytosis that primarily affects the skin. There are three main forms of the condition: maculopapular cutaneous mastocytosis (also called urticaria pigmentosa), solitary cutaneous mastocytoma, and diffuse cutaneous mastocytosis.In 2018, the global Cutaneous Mastocytosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cutaneous Mastocytosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cutaneous Mastocytosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Novartis AG
Mylan NV
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Johnson & Johnson
Bayer AG
Mallinckrodt Pharmaceuticals
Market segment by Type, the product can be split into
Antihistamines
Corticosteroids
Mast Cell Stabilizers
Sympathomimetic Agents (Ephinephrine)
Photochemotherapy
Market segment by Application, split into
Hospitals
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Cutaneous Mastocytosis Treatment status, future forecast, growth opportunity, key market and key players.
To present the Cutaneous Mastocytosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cutaneous Mastocytosis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cutaneous Mastocytosis Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Antihistamines
1.4.3 Corticosteroids
1.4.4 Mast Cell Stabilizers
1.4.5 Sympathomimetic Agents (Ephinephrine)
1.4.6 Photochemotherapy
1.5 Market by Application
1.5.1 Global Cutaneous Mastocytosis Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Cutaneous Mastocytosis Treatment Market Size
2.2 Cutaneous Mastocytosis Treatment Growth Trends by Regions
2.2.1 Cutaneous Mastocytosis Treatment Market Size by Regions (2019-2025)
2.2.2 Cutaneous Mastocytosis Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Cutaneous Mastocytosis Treatment Market Size by by Players
3.1.1 Global Cutaneous Mastocytosis Treatment Revenue by by Players (2014-2019)
3.1.2 Global Cutaneous Mastocytosis Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Cutaneous Mastocytosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Cutaneous Mastocytosis Treatment Key Players Head office and Area Served
3.3 Key Players Cutaneous Mastocytosis Treatment Product/Solution/Service
3.4 Date of Enter into Cutaneous Mastocytosis Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Cutaneous Mastocytosis Treatment Market Size by Type (2014-2019)
4.2 Global Cutaneous Mastocytosis Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Cutaneous Mastocytosis Treatment Market Size (2014-2019)
5.2 Cutaneous Mastocytosis Treatment Key Players in North America
5.3 North America Cutaneous Mastocytosis Treatment Market Size by Type
5.4 North America Cutaneous Mastocytosis Treatment Market Size by Application
6 Europe
6.1 Europe Cutaneous Mastocytosis Treatment Market Size (2014-2019)
6.2 Cutaneous Mastocytosis Treatment Key Players in Europe
6.3 Europe Cutaneous Mastocytosis Treatment Market Size by Type
6.4 Europe Cutaneous Mastocytosis Treatment Market Size by Application
7 China
7.1 China Cutaneous Mastocytosis Treatment Market Size (2014-2019)
7.2 Cutaneous Mastocytosis Treatment Key Players in China
7.3 China Cutaneous Mastocytosis Treatment Market Size by Type
7.4 China Cutaneous Mastocytosis Treatment Market Size by Application
8 Japan
8.1 Japan Cutaneous Mastocytosis Treatment Market Size (2014-2019)
8.2 Cutaneous Mastocytosis Treatment Key Players in Japan
8.3 Japan Cutaneous Mastocytosis Treatment Market Size by Type
8.4 Japan Cutaneous Mastocytosis Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Cutaneous Mastocytosis Treatment Market Size (2014-2019)
9.2 Cutaneous Mastocytosis Treatment Key Players in Southeast Asia
9.3 Southeast Asia Cutaneous Mastocytosis Treatment Market Size by Type
9.4 Southeast Asia Cutaneous Mastocytosis Treatment Market Size by Application
10 India
10.1 India Cutaneous Mastocytosis Treatment Market Size (2014-2019)
10.2 Cutaneous Mastocytosis Treatment Key Players in India
10.3 India Cutaneous Mastocytosis Treatment Market Size by Type
10.4 India Cutaneous Mastocytosis Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Cutaneous Mastocytosis Treatment Market Size (2014-2019)
11.2 Cutaneous Mastocytosis Treatment Key Players in Central & South America
11.3 Central & South America Cutaneous Mastocytosis Treatment Market Size by Type
11.4 Central & South America Cutaneous Mastocytosis Treatment Market Size by Application
12 International Players Profiles
12.1 Novartis AG
12.1.1 Novartis AG Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cutaneous Mastocytosis Treatment Introduction
12.1.4 Novartis AG Revenue in Cutaneous Mastocytosis Treatment Business (2014-2019))
12.1.5 Novartis AG Recent Development
12.2 Mylan NV
12.2.1 Mylan NV Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cutaneous Mastocytosis Treatment Introduction
12.2.4 Mylan NV Revenue in Cutaneous Mastocytosis Treatment Business (2014-2019)
12.2.5 Mylan NV Recent Development
12.3 Teva Pharmaceutical Industries Ltd.
12.3.1 Teva Pharmaceutical Industries Ltd. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cutaneous Mastocytosis Treatment Introduction
12.3.4 Teva Pharmaceutical Industries Ltd. Revenue in Cutaneous Mastocytosis Treatment Business (2014-2019)
12.3.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.4 Bausch Health Companies Inc.
12.4.1 Bausch Health Companies Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cutaneous Mastocytosis Treatment Introduction
12.4.4 Bausch Health Companies Inc. Revenue in Cutaneous Mastocytosis Treatment Business (2014-2019)
12.4.5 Bausch Health Companies Inc. Recent Development
12.5 Pfizer Inc.
12.5.1 Pfizer Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cutaneous Mastocytosis Treatment Introduction
12.5.4 Pfizer Inc. Revenue in Cutaneous Mastocytosis Treatment Business (2014-2019)
12.5.5 Pfizer Inc. Recent Development
12.6 Teva Pharmaceutical Industries Ltd.
12.6.1 Teva Pharmaceutical Industries Ltd. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cutaneous Mastocytosis Treatment Introduction
12.6.4 Teva Pharmaceutical Industries Ltd. Revenue in Cutaneous Mastocytosis Treatment Business (2014-2019)
12.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
12.7 Sanofi S.A.
12.7.1 Sanofi S.A. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cutaneous Mastocytosis Treatment Introduction
12.7.4 Sanofi S.A. Revenue in Cutaneous Mastocytosis Treatment Business (2014-2019)
12.7.5 Sanofi S.A. Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cutaneous Mastocytosis Treatment Introduction
12.8.4 Johnson & Johnson Revenue in Cutaneous Mastocytosis Treatment Business (2014-2019)
12.8.5 Johnson & Johnson Recent Development
12.9 Bayer AG
12.9.1 Bayer AG Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cutaneous Mastocytosis Treatment Introduction
12.9.4 Bayer AG Revenue in Cutaneous Mastocytosis Treatment Business (2014-2019)
12.9.5 Bayer AG Recent Development
12.10 Mallinckrodt Pharmaceuticals
12.10.1 Mallinckrodt Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cutaneous Mastocytosis Treatment Introduction
12.10.4 Mallinckrodt Pharmaceuticals Revenue in Cutaneous Mastocytosis Treatment Business (2014-2019)
12.10.5 Mallinckrodt Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Cutaneous Mastocytosis Treatment Key Market Segments
Table Key Players Cutaneous Mastocytosis Treatment Covered
Table Global Cutaneous Mastocytosis Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Antihistamines Figures
Table Key Players of Antihistamines
Figuer Corticosteroids Figures
Table Key Players of Corticosteroids
Figuer Mast Cell Stabilizers Figures
Table Key Players of Mast Cell Stabilizers
Figuer Sympathomimetic Agents (Ephinephrine) Figures
Table Key Players of Sympathomimetic Agents (Ephinephrine)
Figuer Photochemotherapy Figures
Table Key Players of Photochemotherapy
Table Global Cutaneous Mastocytosis Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Cutaneous Mastocytosis Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Cutaneous Mastocytosis Treatment Report Years Considered
Figure Global Cutaneous Mastocytosis Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Cutaneous Mastocytosis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Cutaneous Mastocytosis Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Cutaneous Mastocytosis Treatment Market Share by Regions 2014-2019
Figure Global Cutaneous Mastocytosis Treatment Market Share by Regions 2014-2019
Figure Global Cutaneous Mastocytosis Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Cutaneous Mastocytosis Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Cutaneous Mastocytosis Treatment Market Share by by Players (2014-2019)
Figure Global Cutaneous Mastocytosis Treatment Market Share by by Players in 2018
Table Global Cutaneous Mastocytosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Cutaneous Mastocytosis Treatment Product/Solution/Service
Table Date of Enter into Cutaneous Mastocytosis Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Cutaneous Mastocytosis Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Cutaneous Mastocytosis Treatment Market Size Share by Type (2014-2019)
Figure Global Cutaneous Mastocytosis Treatment Market Size Market Share by Type (2014-2019)
Table Global Cutaneous Mastocytosis Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Cutaneous Mastocytosis Treatment Market Size Share by Application (2014-2019)
Figure Global Cutaneous Mastocytosis Treatment Market Size Market Share by Application (2014-2019)
Figure Global Cutaneous Mastocytosis Treatment Revenue Market Share by Application in 2018
Figure North America Cutaneous Mastocytosis Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Cutaneous Mastocytosis Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Cutaneous Mastocytosis Treatment Market Share (2018-2019)
Table North America Cutaneous Mastocytosis Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Cutaneous Mastocytosis Treatment Market Share by Type 2014-2019
Table North America Cutaneous Mastocytosis Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Cutaneous Mastocytosis Treatment Market Share by Application 2014-2019
Figure Europe Cutaneous Mastocytosis Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Cutaneous Mastocytosis Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Cutaneous Mastocytosis Treatment Market Share (2018-2019)
Table Europe Cutaneous Mastocytosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Cutaneous Mastocytosis Treatment Market Share by Type 2014-2019
Table Europe Cutaneous Mastocytosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Cutaneous Mastocytosis Treatment Market Share by Application 2014-2019
Figure China Cutaneous Mastocytosis Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Cutaneous Mastocytosis Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Cutaneous Mastocytosis Treatment Market Share (2018-2019)
Table China Cutaneous Mastocytosis Treatment Market Size by Type 2014-2019 (Million US$)
Table China Cutaneous Mastocytosis Treatment Market Share by Type 2014-2019
Table China Cutaneous Mastocytosis Treatment Market Size by Application 2014-2019 (Million US$)
Table China Cutaneous Mastocytosis Treatment Market Share by Application 2014-2019
Figure Japan Cutaneous Mastocytosis Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Cutaneous Mastocytosis Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Cutaneous Mastocytosis Treatment Market Share (2018-2019)
Table Japan Cutaneous Mastocytosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Cutaneous Mastocytosis Treatment Market Share by Type 2014-2019
Table Japan Cutaneous Mastocytosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Cutaneous Mastocytosis Treatment Market Share by Application 2014-2019
Figure Southeast Asia Cutaneous Mastocytosis Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Cutaneous Mastocytosis Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Cutaneous Mastocytosis Treatment Market Share (2018-2019)
Table Southeast Asia Cutaneous Mastocytosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Cutaneous Mastocytosis Treatment Market Share by Type 2014-2019
Table Southeast Asia Cutaneous Mastocytosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Cutaneous Mastocytosis Treatment Market Share by Application 2014-2019
Figure India Cutaneous Mastocytosis Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Cutaneous Mastocytosis Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Cutaneous Mastocytosis Treatment Market Share (2018-2019)
Table India Cutaneous Mastocytosis Treatment Market Size by Type 2014-2019 (Million US$)
Table India Cutaneous Mastocytosis Treatment Market Share by Type 2014-2019
Table India Cutaneous Mastocytosis Treatment Market Size by Application 2014-2019 (Million US$)
Table India Cutaneous Mastocytosis Treatment Market Share by Application 2014-2019
Figure Central & South America Cutaneous Mastocytosis Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Cutaneous Mastocytosis Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Cutaneous Mastocytosis Treatment Market Share (2018-2019)
Table Central & South America Cutaneous Mastocytosis Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Cutaneous Mastocytosis Treatment Market Share by Type 2014-2019
Table Central & South America Cutaneous Mastocytosis Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Cutaneous Mastocytosis Treatment Market Share by Application 2014-2019
Table Novartis AG Company Details
Table Novartis AG Revenue in Cutaneous Mastocytosis Treatment Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2014-2019)
Table Novartis AG Recent Development
Table Mylan NV Company Details
Table Mylan NV Revenue in Cutaneous Mastocytosis Treatment Business 2014-2019 (Million US$)
Figure Mylan NV Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2014-2019)
Table Mylan NV Recent Development
Table Teva Pharmaceutical Industries Ltd. Company Details
Table Teva Pharmaceutical Industries Ltd. Revenue in Cutaneous Mastocytosis Treatment Business 2014-2019 (Million US$)
Figure Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2014-2019)
Table Teva Pharmaceutical Industries Ltd. Recent Development
Table Bausch Health Companies Inc. Company Details
Table Bausch Health Companies Inc. Revenue in Cutaneous Mastocytosis Treatment Business 2014-2019 (Million US$)
Figure Bausch Health Companies Inc. Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2014-2019)
Table Bausch Health Companies Inc. Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Cutaneous Mastocytosis Treatment Business 2014-2019 (Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Teva Pharmaceutical Industries Ltd. Company Details
Table Teva Pharmaceutical Industries Ltd. Revenue in Cutaneous Mastocytosis Treatment Business 2014-2019 (Million US$)
Figure Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2014-2019)
Table Teva Pharmaceutical Industries Ltd. Recent Development
Table Sanofi S.A. Company Details
Table Sanofi S.A. Revenue in Cutaneous Mastocytosis Treatment Business 2014-2019 (Million US$)
Figure Sanofi S.A. Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2014-2019)
Table Sanofi S.A. Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Cutaneous Mastocytosis Treatment Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Cutaneous Mastocytosis Treatment Business 2014-2019 (Million US$)
Figure Bayer AG Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2014-2019)
Table Bayer AG Recent Development
Table Mallinckrodt Pharmaceuticals Company Details
Table Mallinckrodt Pharmaceuticals Revenue in Cutaneous Mastocytosis Treatment Business 2014-2019 (Million US$)
Figure Mallinckrodt Pharmaceuticals Revenue Growth Rate in Cutaneous Mastocytosis Treatment Business (2014-2019)
Table Mallinckrodt Pharmaceuticals Recent Development
Table Global Cutaneous Mastocytosis Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Cutaneous Mastocytosis Treatment Market Size Share by Regions (2019-2025)
Figure Global Cutaneous Mastocytosis Treatment Market Size Share by Regions in 2025
Figure North America Cutaneous Mastocytosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Cutaneous Mastocytosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Cutaneous Mastocytosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Cutaneous Mastocytosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Cutaneous Mastocytosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Cutaneous Mastocytosis Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Cutaneous Mastocytosis Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Cutaneous Mastocytosis Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Cutaneous Mastocytosis Treatment Market Size by Product (2019-2025)
Figure Global Cutaneous Mastocytosis Treatment Market Size by Product in 2025
Table Global Cutaneous Mastocytosis Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Cutaneous Mastocytosis Treatment Market Size by Application (2019-2025)
Figure Global Cutaneous Mastocytosis Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
皮膚線維症の治療の世界市場：市場規模・現状・予測 Cutaneous fibrosis is the accumulation of extracellular matrix (ECM) components in the dermis, leading to compromised function and altered architecture of the dermis. Development of fibrosis occurs naturally during scar formation in wound repair or is a pathological process in pro-fibrotic diseases.…- 世界の皮膚リーシュマニア症薬市場：動向・競争分析 Cutaneous leishmaniasis is the most common syndrome and can produce ulcers that have the potential of stimulating a periosteal reaction if the ulcer occurs near bone.In 2018, the global Cutaneous Leishmaniasis Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at …
- 巨細胞性動脈炎治療の世界市場：市場規模・現状・予測 Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age.Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin h…
- 幹細胞脱毛症治療の世界市場：市場規模・現状・予測 The stem cells, which are stimulated by the drug, replenish or restore cells associated with the induction of hair growth.In 2018, the global Stem Cell Alopecia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-202…
- 形質細胞腫瘍治療の世界市場：市場規模・現状・予測 Plasma cell neoplasms are diseases in which the body makes too many plasma cells.The plasma cells also make an antibody protein, called M protein, that is not needed by the body and does not help fight infection. These antibody proteins build up in the bone marrow and can cause the blood to thicken …